LOVFF OTC
Cannara Biotech Inc.
1W: -2.0%
1M: +2.1%
3M: +25.4%
YTD: +13.8%
1Y: +15.6%
3Y: +113.1%
5Y: +2.8%
$1.48
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$146.2M
52W Range1.1095-1.66
Volume1,100
Avg Volume14,725
Beta0.39
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOZohar Krivorot
Employees452
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2019-01-18
Websitecannara.ca
333 Decarie Blvd. Suite 200
Saint-Laurent, QC H4N 3M9
CA
Saint-Laurent, QC H4N 3M9
CA
514-543-4200
About Cannara Biotech Inc.
Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivative products in Canada. The company operates in two segment Cannabis operations and Real estate operations. It offers its products under TRIBAL, nugz, and ORCHID CBD brand name. The company sells its products through wholesalers and online merchandisers. In addition, it engages in the real estate operations. Cannara Biotech Inc. was incorporated in 2017 and is headquartered in Saint-Laurent, Canada.
Latest News
Cannara Reports Record Q3 Revenues and Continued Profitability Accompanied By Expanding National Distribution and Accelerated Capacity Expansion
Cannara annonce un chiffre d’affaires record au troisième trimestre et une rentabilité soutenue, parallèlement à l’extension de sa distribution nationale et à l’accélération de l’augmentation de ses capacités
Cannara Biotech reports Q3 results
Cannara Completes Acquisition of Medican Organic Inc.
Cannara Completes Acquisition of Medican Organic Inc.
Recent Insider Trades
No insider trades found